Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Barbara Frigeni

Showing results (11-20 of 32) with videos related to

Pageof 4
Sort By:
Multiple Sclerosis and Related Disorders|April 21, 2015
Glatiramer acetate-induced hepatitis in a young female patient with multiple sclerosisSara La Gioia, Giuseppe Bacis, Aurelio Sonzogni, et al.
Journal of the Peripheral Nervous System : JPNS|February 5, 2009
Role of a pre-existing neuropathy on the course of bortezomib-induced peripheral neurotoxicityFrancesca Lanzani, Laura Mattavelli, Barbara Frigeni, et al.
European Journal of Cancer (Oxford, England : 1990)|January 5, 2010
Chemotherapy-Induced Peripheral Neurotoxicity assessment: a critical revision of the currently available toolsGuido Cavaletti, Barbara Frigeni, Francesca Lanzani, et al.
European Journal of Neurology|September 22, 2020
COVID-19 provoking Guillain-Barré syndrome: The Bergamo case seriesCamillo Foresti, Maria Cristina Servalli, Barbara Frigeni, et al.
Journal of the Peripheral Nervous System : JPNS|October 19, 2011
Chemotherapy-induced peripheral neurotoxicity can be misdiagnosed by the National Cancer Institute Common Toxicity scaleBarbara Frigeni, Marialuisa Piatti, Francesca Lanzani, et al.
Multiple Sclerosis and Related Disorders|July 27, 2016
Erythroblastaemia in natalizumab-treated patients with multiple sclerosisSara La Gioia, Michela Seghezzi, Valeria Barcella, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|July 2, 2013
Early predictors of oxaliplatin-induced cumulative neuropathy in colorectal cancer patientsRoser Velasco, Jordi Bruna, Chiara Briani, et al.
Journal of the Peripheral Nervous System : JPNS|January 14, 2015
Long-term course of oxaliplatin-induced polyneuropathy: a prospective 2-year follow-up studyChiara Briani, Andreas A Argyriou, Cristina Izquierdo, et al.
Journal of the Peripheral Nervous System : JPNS|September 18, 2007
The Total Neuropathy Score as an assessment tool for grading the course of chemotherapy-induced peripheral neurotoxicity: comparison with the National Cancer Institute-Common Toxicity ScaleGuido Cavaletti, Barbara Frigeni, Francesca Lanzani, et al.
Neurophysiologie Clinique = Clinical Neurophysiology|March 9, 2021
Electrophysiological features of acute inflammatory demyelinating polyneuropathy associated with SARS-CoV-2 infectionAntonino Uncini, Camillo Foresti, Barbara Frigeni, et al.
Pageof 4

Showing results (11-20 of 32) with videos related to

Sort By:
Pageof 4
Multiple Sclerosis and Related Disorders|April 21, 2015
Glatiramer acetate-induced hepatitis in a young female patient with multiple sclerosisSara La Gioia, Giuseppe Bacis, Aurelio Sonzogni, et al.
Journal of the Peripheral Nervous System : JPNS|February 5, 2009
Role of a pre-existing neuropathy on the course of bortezomib-induced peripheral neurotoxicityFrancesca Lanzani, Laura Mattavelli, Barbara Frigeni, et al.
European Journal of Cancer (Oxford, England : 1990)|January 5, 2010
Chemotherapy-Induced Peripheral Neurotoxicity assessment: a critical revision of the currently available toolsGuido Cavaletti, Barbara Frigeni, Francesca Lanzani, et al.
European Journal of Neurology|September 22, 2020
COVID-19 provoking Guillain-Barré syndrome: The Bergamo case seriesCamillo Foresti, Maria Cristina Servalli, Barbara Frigeni, et al.
Journal of the Peripheral Nervous System : JPNS|October 19, 2011
Chemotherapy-induced peripheral neurotoxicity can be misdiagnosed by the National Cancer Institute Common Toxicity scaleBarbara Frigeni, Marialuisa Piatti, Francesca Lanzani, et al.
Multiple Sclerosis and Related Disorders|July 27, 2016
Erythroblastaemia in natalizumab-treated patients with multiple sclerosisSara La Gioia, Michela Seghezzi, Valeria Barcella, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|July 2, 2013
Early predictors of oxaliplatin-induced cumulative neuropathy in colorectal cancer patientsRoser Velasco, Jordi Bruna, Chiara Briani, et al.
Journal of the Peripheral Nervous System : JPNS|January 14, 2015
Long-term course of oxaliplatin-induced polyneuropathy: a prospective 2-year follow-up studyChiara Briani, Andreas A Argyriou, Cristina Izquierdo, et al.
Journal of the Peripheral Nervous System : JPNS|September 18, 2007
The Total Neuropathy Score as an assessment tool for grading the course of chemotherapy-induced peripheral neurotoxicity: comparison with the National Cancer Institute-Common Toxicity ScaleGuido Cavaletti, Barbara Frigeni, Francesca Lanzani, et al.
Neurophysiologie Clinique = Clinical Neurophysiology|March 9, 2021
Electrophysiological features of acute inflammatory demyelinating polyneuropathy associated with SARS-CoV-2 infectionAntonino Uncini, Camillo Foresti, Barbara Frigeni, et al.
Pageof 4